Ocugen, Inc. (OCGN) Fundamentals

Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets.
SHARE INFORMATION
Market Cap$ 491,709,750
Shares Outstanding215,662,171
Float157,920,802
Percent Float73.23%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.29
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions275
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months15,833,826
Institutional Holdings Percent75.4%
Institutional Sold Previous 3 Months3,205,693
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months2,579,718
Insider Holdings Percent1.4
Insider Sold Previous 3 Months351,146
Insider Shares Owned2,921,118
TRADING INFO
52 Week High$ 17.65
52 Week Low$ 2.10
52 Week High Change$ -79.10
21 Day Moving Average$ 2.5938
21 Day Extended Moving Average$ 2.5827
50 Day Moving Average$ 2.9369
50 Day Extended Moving Average$ 2.9925
200 Day Moving Average$ 5.6757
200 Day Extended Moving Average$ 4.7607
10 Day Average Volume6,414,522
20 Day Average Volume6,702,159
30 Day Average Volume7,075,746
50 Day Average Volume10,060,517
Alpha0.094375
Beta4.6232
Standard Deviation0.992118
R20.048657
7 Day Price Change$ -0.02
7 Day Percent Change-0.87%
21 Day Price Change$ -0.48
21 Day Percent Change-17.39%
30 Day Price Change$ -0.98
30 Day Percent Change-30.06%
Month to Date Price Change$ 0.09
Month to Date Percent Change4.11%
Quarter to Date Price Change$ -1.02
Quarter to Date Percent Change-30.91%
180 Day Price Change$ -7.96
180 Day Percent Change-77.73%
200 Day Price Change$ -6.38
200 Day Percent Change-73.67%
Year to Date Price Change$ -2.27
Year to Date Percent Change-49.89%

Ocugen, Inc. (OCGN) Key Ratios

PROFITABILITY
EBIT Margin999,999.99%
EBITDA Margin9,999,999.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.60
Total Debt To Equity0.00
Int Coverage-738.50
Current Ratio14.70
Leverage Ratio1.10
Quick Ratio13.60
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio-8.60
Enterprise Value$ 447,504,427
Price to Sales0.00
Price to Free Cash-12.40
PE High Last 5 Years-0.40
Price To Book5.60
Price To Cash Flow0.00
PE Low Last 5 Years-4.50
Price to Tangible Book5.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-87.68
Return on Equity-99.46
Return on Capital-94.65

Ocugen, Inc. (OCGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOShankar Musunuri
Emplyoees56
Last AuditUE
CIK0001372299
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address263 Great Valley Parkway
Suite 160
Malvern, PA 19355
Websitehttps://www.ocugen.com
Facsimile-
Telephone+1 484 328-4701
EmailIR@ocugen.com


Your Recent History
NASDAQ
OCGN
Ocugen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.